DOUGLAS E. WILLIAMS - 02 Nov 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
EVP & President, R&D
Signature
/s/ Julie Shah, Attorney-in-Fact for Douglas E. Williams
Issuer symbol
SANA
Transactions as of
02 Nov 2023
Net transactions value
$0
Form type
4
Filing time
03 Nov 2023, 16:14:01 UTC
Previous filing
11 Apr 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Restricted Stock Units Award $0 +10,000 $0.000000 10,000 02 Nov 2023 Common Stock 10,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
F2 The restricted stock units will vest in full on January 2, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.